{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:26:51Z","timestamp":1782818811196,"version":"3.54.5"},"reference-count":47,"publisher":"American Diabetes Association","issue":"10","license":[{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01-HD-40787"],"award-info":[{"award-number":["R01-HD-40787"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01-DK-111038"],"award-info":[{"award-number":["R01-DK-111038"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01-HD-28016"],"award-info":[{"award-number":["R01-HD-28016"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["K24-HD-01464"],"award-info":[{"award-number":["K24-HD-01464"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01-DK-114504"],"award-info":[{"award-number":["R01-DK-114504"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["UL1-RR-0249139"],"award-info":[{"award-number":["UL1-RR-0249139"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["Distinguished Clinical Scientist Award"],"award-info":[{"award-number":["Distinguished Clinical Scientist Award"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-DK-111038"],"award-info":[{"award-number":["R01-DK-111038"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-DK-114504-01A"],"award-info":[{"award-number":["R01-DK-114504-01A"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K12-AWDA-10768"],"award-info":[{"award-number":["K12-AWDA-10768"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["GR-103182"],"award-info":[{"award-number":["GR-103182"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000938","name":"Robert E. Leet and Clara Guthrie Patterson Trust","doi-asserted-by":"publisher","award":["Research Mentored Award"],"award-info":[{"award-number":["Research Mentored Award"]}],"id":[{"id":"10.13039\/100000938","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007479","name":"Fondazione Cassa Di Risparmio di Padova e Rovigo","doi-asserted-by":"publisher","award":["CARIPARO 2016-2020"],"award-info":[{"award-number":["CARIPARO 2016-2020"]}],"id":[{"id":"10.13039\/100007479","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Italian Ministry for Education","award":["Departments of Excellence"],"award-info":[{"award-number":["Departments of Excellence"]}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>The risk genotype for the common variant rs7903146 of the transcription factor 7-like-2 (TCF7L2) gene has been found to affect the incretin response in healthy and obese adults; however, whether a similar functional defect is also present in obese adolescents remains unexplored. Herein, we examined the functional effect of the rs7903146 variant in the TCF7L2 gene on the incretin effect and determined its translational metabolic manifestation by performing deep phenotyping of the incretin system, \u03b2-cell function relative to insulin sensitivity, the gastrointestinal-induced glucose disposal (GIGD) in obese youth with normal and impaired glucose tolerance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>Thirty-nine obese adolescents without diabetes (median age 15 [25th, 75th percentile 14, 18] years; BMI 37 [33, 43] kg\/m2) were genotyped for the rs7903146 variant of TCF7L2 and underwent a 3-h oral glucose tolerance test (OGTT) followed by an isoglycemic intravenous glucose infusion (iso-intravenous glucose tolerance test [IVGTT]) to match the plasma glucose concentrations during the OGTT and a hyperglycemic clamp with arginine stimulation. The incretin effect was measured as 100 * (AUC-SROGTT \u2212 AUC-SRiso-IVGTT) \/ AUC-SROGTT, where AUC-SR = area under the curve of C-peptide secretion rate. Participants were grouped into tertiles according to the percentage incretin effect (high, moderate, and low) to describe their metabolic phenotype.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>The presence of T risk allele for TCF7L2 was associated with a markedly reduced incretin effect compared with the wild-type genotype (0.3% [\u22127.2, 14] vs. 37.8% [12.5, 52.4], P &amp;lt; 0.002). When the cohort was stratified by incretin effect, the high, moderate, and low incretin effect groups did not differ with respect to anthropometric features, while the low incretin effect group exhibited higher 1-h glucose (P = 0.015) and a reduced disposition index, insulin sensitivity, and insulin clearance compared with the high incretin effect group. GIGD was reduced in the low incretin effect group (P = 0.001). The three groups did not differ with respect to intravenous glucose-induced insulin secretion and arginine response during the hyperglycemic clamp.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>A reduced incretin effect and its association with the TCF7L2 variant rs7903146 identify an early metabolic phenotype in obese youth without diabetes, featuring a higher plasma glucose peak at 1 h; lower insulin secretion, sensitivity, and clearance; and GIGD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc20-0445","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T22:30:40Z","timestamp":1597185040000},"page":"2553-2563","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":12,"title":["A Reduced Incretin Effect Mediated by the rs7903146 Variant in the <i>TCF7L2<\/i> Gene Is an Early Marker of \u03b2-Cell Dysfunction in Obese Youth"],"prefix":"10.2337","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8885-3056","authenticated-orcid":false,"given":"Alfonso","family":"Galderisi","sequence":"first","affiliation":[{"name":"Pediatrics Endocrinology and Diabetes Section, Department of Pediatrics, Yale School of Medicine, New Haven, CT"},{"name":"Department of Woman and Child\u2019s Health, University of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7633-1346","authenticated-orcid":false,"given":"Domenico","family":"Tric\u00f2","sequence":"additional","affiliation":[{"name":"Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy"},{"name":"Institute of Life Sciences, Sant\u2019Anna School of Advanced Studies, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Pierpont","sequence":"additional","affiliation":[{"name":"Pediatrics Endocrinology and Diabetes Section, Department of Pediatrics, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Shabanova","sequence":"additional","affiliation":[{"name":"Pediatrics Endocrinology and Diabetes Section, Department of Pediatrics, Yale School of Medicine, New Haven, CT"},{"name":"Yale School of Public Health, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Samuels","sequence":"additional","affiliation":[{"name":"Pediatrics Endocrinology and Diabetes Section, Department of Pediatrics, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Dalla Man","sequence":"additional","affiliation":[{"name":"Department of Information Engineering, University of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Galuppo","sequence":"additional","affiliation":[{"name":"Pediatrics Endocrinology and Diabetes Section, Department of Pediatrics, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6437-4173","authenticated-orcid":false,"given":"Nicola","family":"Santoro","sequence":"additional","affiliation":[{"name":"Pediatrics Endocrinology and Diabetes Section, Department of Pediatrics, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7523-5053","authenticated-orcid":false,"given":"Sonia","family":"Caprio","sequence":"additional","affiliation":[{"name":"Pediatrics Endocrinology and Diabetes Section, Department of Pediatrics, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"key":"2022031223574597800_B1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S2213-8587(15)00482-9","article-title":"The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions","volume":"4","author":"Nauck","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022031223574597800_B2","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.2337\/db07-0100","article-title":"Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state","volume":"56","author":"Knop","year":"2007","journal-title":"Diabetes"},{"key":"2022031223574597800_B3","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2337\/db13-1455","article-title":"Defining the role of GLP-1 in the enteroinsulinar axis in type 2 diabetes using DPP-4 inhibition and GLP-1 receptor blockade","volume":"63","author":"Aulinger","year":"2014","journal-title":"Diabetes"},{"key":"2022031223574597800_B4","doi-asserted-by":"crossref","unstructured":"Aulinger\u2008BA, Vahl\u2008TP, Prigeon\u2008RL, D\u2019Alessio\u2008DA, Elder\u2008DA. The incretin effect in obese adolescents with and without type 2 diabetes: impaired or intact? Am J Physiol Endocrinol Metab\u20082016;310:E774\u2013E781","DOI":"10.1152\/ajpendo.00496.2015"},{"key":"2022031223574597800_B5","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2337\/dc12-1861","article-title":"One-hour glucose during an oral glucose challenge prospectively predicts \u03b2-cell deterioration and prediabetes in obese Hispanic youth","volume":"36","author":"Kim","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031223574597800_B6","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.2337\/db13-1951","article-title":"\u03b2-cell function, incretin effect, and incretin hormones in obese youth along the span of glucose tolerance from normal to prediabetes to type 2 diabetes","volume":"63","author":"Michaliszyn","year":"2014","journal-title":"Diabetes"},{"key":"2022031223574597800_B7","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.2337\/dc17-0290","article-title":"The rs7903146 variant in the TCF7L2 gene increases the risk of prediabetes\/type 2 diabetes in obese adolescents by impairing \u03b2-cell function and hepatic insulin sensitivity","volume":"40","author":"Cropano","year":"2017","journal-title":"Diabetes Care"},{"key":"2022031223574597800_B8","doi-asserted-by":"crossref","unstructured":"Tamborlane\u2008WV, Barrientos-P\u00e9rez\u2008M, Fainberg\u2008U, et al.; Ellipse Trial Investigators. Liraglutide in children and adolescents with type 2 diabetes. N Engl J Med\u20082019;381:637\u2013646","DOI":"10.1056\/NEJMoa1903822"},{"key":"2022031223574597800_B9","doi-asserted-by":"crossref","first-page":"E774","DOI":"10.1152\/ajpendo.00496.2015","article-title":"The incretin effect in obese adolescents with and without type 2 diabetes: impaired or intact","volume":"310","author":"Aulinger","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031223574597800_B10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2337\/db09-1169","article-title":"TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action","volume":"59","author":"Villareal","year":"2010","journal-title":"Diabetes"},{"key":"2022031223574597800_B11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa062418","article-title":"TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program","volume":"355","author":"Florez","year":"2006","journal-title":"N Engl J Med"},{"key":"2022031223574597800_B12","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/jcem-63-2-492","article-title":"Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses","volume":"63","author":"Nauck","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031223574597800_B13","doi-asserted-by":"crossref","first-page":"E54","DOI":"10.1152\/ajpendo.00033.2006","article-title":"Incretin effect potentiates beta-cell responsivity to glucose as well as to its rate of change: OGTT and matched intravenous study","volume":"292","author":"Campioni","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031223574597800_B14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/adc.44.235.291","article-title":"Variations in pattern of pubertal changes in girls","volume":"44","author":"Marshall","year":"1969","journal-title":"Arch Dis Child"},{"key":"2022031223574597800_B15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/adc.45.239.13","article-title":"Variations in the pattern of pubertal changes in boys","volume":"45","author":"Marshall","year":"1970","journal-title":"Arch Dis Child"},{"key":"2022031223574597800_B16","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/dom.13640","article-title":"One-hour post-load plasma glucose predicts progression to prediabetes in a multi-ethnic cohort of obese youths","volume":"21","author":"Tric\u00f2","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"2022031223574597800_B17","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.2337\/dc18-S015","article-title":"15. Diabetes advocacy: Standards of Medical Care in Diabetes\u20142018","volume":"41","author":"American Diabetes Association","year":"2018","journal-title":"Diabetes Care"},{"key":"2022031223574597800_B18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2337\/diab.37.2.200","article-title":"Incretin effect due to increased secretion and decreased clearance of insulin in normal humans","volume":"37","author":"Shuster","year":"1988","journal-title":"Diabetes"},{"key":"2022031223574597800_B19","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2337\/diabetes.41.3.368","article-title":"Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance","volume":"41","author":"Van Cauter","year":"1992","journal-title":"Diabetes"},{"key":"2022031223574597800_B20","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.2337\/dc18-0244","article-title":"Metabolic contrasts between youth and adults with impaired glucose tolerance or recently diagnosed type 2 diabetes: I. Observations using the hyperglycemic clamp","volume":"41","author":"RISE Consortium","year":"2018","journal-title":"Diabetes Care"},{"key":"2022031223574597800_B21","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1475-097X.1992.tb00357.x","article-title":"Critical evaluation of the \u2018heated-hand-technique\u2019 for obtaining \u2018arterialized\u2019 venous blood: incomplete arterialization and alterations in glucagon responses","volume":"12","author":"Nauck","year":"1992","journal-title":"Clin Physiol"},{"key":"2022031223574597800_B22","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2337\/db13-1198","article-title":"The oral minimal model method","volume":"63","author":"Cobelli","year":"2014","journal-title":"Diabetes"},{"key":"2022031223574597800_B23","doi-asserted-by":"crossref","first-page":"E954","DOI":"10.1152\/ajpendo.00076.2005","article-title":"Insulin sensitivity by oral glucose minimal models: validation against clamp","volume":"289","author":"Dalla Man","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031223574597800_B24","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.2337\/db05-1692","article-title":"Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction","volume":"55","author":"Basu","year":"2006","journal-title":"Diabetes"},{"key":"2022031223574597800_B25","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1210\/jcem-51-3-520","article-title":"Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior","volume":"51","author":"Eaton","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031223574597800_B26","doi-asserted-by":"crossref","first-page":"E1115","DOI":"10.1152\/ajpendo.00705.2009","article-title":"A model of GLP-1 action on insulin secretion in nondiabetic subjects","volume":"298","author":"Dalla Man","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031223574597800_B27","doi-asserted-by":"crossref","first-page":"E637","DOI":"10.1152\/ajpendo.00319.2003","article-title":"Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method","volume":"287","author":"Dalla Man","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031223574597800_B28","first-page":"884","article-title":"Roles of the gut in glucose homeostasis","volume-title":"Diabetes Care","author":"Holst","year":"2016"},{"key":"2022031223574597800_B29","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.2337\/db15-1373","article-title":"Hepatic and extrahepatic insulin clearance are differentially regulated: results from a novel model-based analysis of intravenous glucose tolerance data","volume":"65","author":"Polidori","year":"2016","journal-title":"Diabetes"},{"key":"2022031223574597800_B30","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1210\/jc.2018-01808","article-title":"Hepatic insulin extraction in NAFLD is related to insulin resistance rather than liver fat content","volume":"104","author":"Utzschneider","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031223574597800_B31","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2337\/diabetes.54.1.166","article-title":"Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes","volume":"54","author":"Lyssenko","year":"2005","journal-title":"Diabetes"},{"key":"2022031223574597800_B32","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2337\/dc09-0523","article-title":"Regression from pre-diabetes to normal glucose regulation in the Diabetes Prevention Program","volume":"32","author":"Perreault","year":"2009","journal-title":"Diabetes Care"},{"key":"2022031223574597800_B33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00592-012-0384-3","article-title":"1-Hour plasma glucose in obese youth","volume":"49","author":"Manco","year":"2012","journal-title":"Acta Diabetol"},{"key":"2022031223574597800_B34","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1210\/me.2008-0135","article-title":"The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus","volume":"22","author":"Jin","year":"2008","journal-title":"Mol Endocrinol"},{"key":"2022031223574597800_B35","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1172\/JCI30706","article-title":"Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes","volume":"117","author":"Lyssenko","year":"2007","journal-title":"J Clin Invest"},{"key":"2022031223574597800_B36","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1007\/s00125-009-1307-x","article-title":"The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men","volume":"52","author":"Pilgaard","year":"2009","journal-title":"Diabetologia"},{"key":"2022031223574597800_B37","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2337\/dc17-1386","article-title":"TCF7L2 genetic variation augments incretin resistance and influences response to a sulfonylurea and metformin: the Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH)","volume":"41","author":"Srinivasan","year":"2018","journal-title":"Diabetes Care"},{"key":"2022031223574597800_B38","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s00125-008-1025-9","article-title":"Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes","volume":"51","author":"Florez","year":"2008","journal-title":"Diabetologia"},{"key":"2022031223574597800_B39","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.cell.2012.10.053","article-title":"Diabetes risk gene and Wnt effector Tcf7l2\/TCF4 controls hepatic response to perinatal and adult metabolic demand","volume":"151","author":"Boj","year":"2012","journal-title":"Cell"},{"key":"2022031223574597800_B40","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ng1732","article-title":"Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes","volume":"38","author":"Grant","year":"2006","journal-title":"Nat Genet"},{"key":"2022031223574597800_B41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1172\/JCI113338","article-title":"Quantitative study of insulin secretion and clearance in normal and obese subjects","volume":"81","author":"Polonsky","year":"1988","journal-title":"J Clin Invest"},{"key":"2022031223574597800_B42","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1210\/jc.2014-4009","article-title":"\u03b2-Cell sensitivity to GLP-1 in healthy humans is variable and proportional to insulin sensitivity","volume":"100","author":"Aulinger","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031223574597800_B43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF02427280","article-title":"Reduced incretin effect in type 2 (non-insulin-dependent) diabetes","volume":"29","author":"Nauck","year":"1986","journal-title":"Diabetologia"},{"key":"2022031223574597800_B44","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1210\/jc.2009-0921","article-title":"Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitus","volume":"94","author":"Hare","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031223574597800_B45","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.2337\/db19-0120","article-title":"Lower insulin clearance parallels a reduced insulin sensitivity in obese youths and is associated with a decline in \u03b2-cell function over time","volume":"68","author":"Galderisi","year":"2019","journal-title":"Diabetes"},{"key":"2022031223574597800_B46","first-page":"1396","article-title":"Relationships between gastric emptying, postprandial glycemia, and incretin hormones","volume-title":"Diabetes Care","author":"Marathe","year":"2013"},{"key":"2022031223574597800_B47","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI118411","article-title":"Gastric emptying and release of incretin hormones after glucose ingestion in humans","volume":"97","author":"Schirra","year":"1996","journal-title":"J Clin Invest"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc20-0445","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/10\/2553\/630450\/dc200445.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/10\/2553\/630450\/dc200445.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T03:56:51Z","timestamp":1647143811000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/43\/10\/2553\/35958\/A-Reduced-Incretin-Effect-Mediated-by-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,11]]},"references-count":47,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,8,11]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc20-0445","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,11]]}}}